Advisory Panel Endorses Boston Scientific’s Watchman Left Atrial Appendage Closure Device
This article was originally published in The Gray Sheet
Executive Summary
FDA’s Circulatory System Devices advisory panel voted 13-1 to recommend approval of the firm’s PMA for the Watchman device as an alternative to warfarin therapy for stroke prevention in atrial fibrillation patients for whom long-term anticoagulant therapy is too risky.